Approval Year
Substance Class |
Protein
Created
by
admin
on
Edited
Sat Dec 16 00:30:28 GMT 2023
by
admin
on
Sat Dec 16 00:30:28 GMT 2023
|
Protein Type | GROWTH FACTOR |
Protein Sub Type | ERYTHROPOIETIN |
Sequence Origin | HUMAN |
Sequence Type | COMPLETE |
Record UNII |
64FS3BFH5W
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Related Record | Type |
---|
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Official Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-VATC |
QB03XA01
Created by
admin on Sat Dec 16 00:30:28 GMT 2023 , Edited by admin on Sat Dec 16 00:30:28 GMT 2023
|
||
|
FDA ORPHAN DRUG |
18987
Created by
admin on Sat Dec 16 00:30:28 GMT 2023 , Edited by admin on Sat Dec 16 00:30:28 GMT 2023
|
||
|
WHO-ATC |
B03XA01
Created by
admin on Sat Dec 16 00:30:28 GMT 2023 , Edited by admin on Sat Dec 16 00:30:28 GMT 2023
|
||
|
NDF-RT |
N0000008193
Created by
admin on Sat Dec 16 00:30:28 GMT 2023 , Edited by admin on Sat Dec 16 00:30:28 GMT 2023
|
||
|
NDF-RT |
N0000008193
Created by
admin on Sat Dec 16 00:30:28 GMT 2023 , Edited by admin on Sat Dec 16 00:30:28 GMT 2023
|
||
|
FDA ORPHAN DRUG |
17886
Created by
admin on Sat Dec 16 00:30:28 GMT 2023 , Edited by admin on Sat Dec 16 00:30:28 GMT 2023
|
||
|
NDF-RT |
N0000009319
Created by
admin on Sat Dec 16 00:30:28 GMT 2023 , Edited by admin on Sat Dec 16 00:30:28 GMT 2023
|
||
|
NDF-RT |
N0000175665
Created by
admin on Sat Dec 16 00:30:28 GMT 2023 , Edited by admin on Sat Dec 16 00:30:28 GMT 2023
|
||
|
FDA ORPHAN DRUG |
341711
Created by
admin on Sat Dec 16 00:30:28 GMT 2023 , Edited by admin on Sat Dec 16 00:30:28 GMT 2023
|
||
|
NDF-RT |
N0000008193
Created by
admin on Sat Dec 16 00:30:28 GMT 2023 , Edited by admin on Sat Dec 16 00:30:28 GMT 2023
|
||
|
NDF-RT |
N0000008193
Created by
admin on Sat Dec 16 00:30:28 GMT 2023 , Edited by admin on Sat Dec 16 00:30:28 GMT 2023
|
||
|
NDF-RT |
N0000008193
Created by
admin on Sat Dec 16 00:30:28 GMT 2023 , Edited by admin on Sat Dec 16 00:30:28 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
64FS3BFH5W
Created by
admin on Sat Dec 16 00:30:28 GMT 2023 , Edited by admin on Sat Dec 16 00:30:28 GMT 2023
|
PRIMARY | |||
|
DB00016
Created by
admin on Sat Dec 16 00:30:28 GMT 2023 , Edited by admin on Sat Dec 16 00:30:28 GMT 2023
|
PRIMARY | |||
|
4921
Created by
admin on Sat Dec 16 00:30:28 GMT 2023 , Edited by admin on Sat Dec 16 00:30:28 GMT 2023
|
PRIMARY | |||
|
m5014
Created by
admin on Sat Dec 16 00:30:28 GMT 2023 , Edited by admin on Sat Dec 16 00:30:28 GMT 2023
|
PRIMARY | Merck Index | ||
|
2047589
Created by
admin on Sat Dec 16 00:30:28 GMT 2023 , Edited by admin on Sat Dec 16 00:30:28 GMT 2023
|
PRIMARY | |||
|
SUB13707MIG
Created by
admin on Sat Dec 16 00:30:28 GMT 2023 , Edited by admin on Sat Dec 16 00:30:28 GMT 2023
|
PRIMARY | |||
|
DTXSID7039678
Created by
admin on Sat Dec 16 00:30:28 GMT 2023 , Edited by admin on Sat Dec 16 00:30:28 GMT 2023
|
PRIMARY | |||
|
D004921
Created by
admin on Sat Dec 16 00:30:28 GMT 2023 , Edited by admin on Sat Dec 16 00:30:28 GMT 2023
|
PRIMARY | |||
|
64FS3BFH5W
Created by
admin on Sat Dec 16 00:30:28 GMT 2023 , Edited by admin on Sat Dec 16 00:30:28 GMT 2023
|
PRIMARY | |||
|
234-317-2
Created by
admin on Sat Dec 16 00:30:28 GMT 2023 , Edited by admin on Sat Dec 16 00:30:28 GMT 2023
|
PRIMARY | |||
|
1248218
Created by
admin on Sat Dec 16 00:30:28 GMT 2023 , Edited by admin on Sat Dec 16 00:30:28 GMT 2023
|
PRIMARY | |||
|
m5014
Created by
admin on Sat Dec 16 00:30:28 GMT 2023 , Edited by admin on Sat Dec 16 00:30:28 GMT 2023
|
PRIMARY | Merck Index | ||
|
m5014
Created by
admin on Sat Dec 16 00:30:28 GMT 2023 , Edited by admin on Sat Dec 16 00:30:28 GMT 2023
|
PRIMARY | Merck Index | ||
|
m5014
Created by
admin on Sat Dec 16 00:30:28 GMT 2023 , Edited by admin on Sat Dec 16 00:30:28 GMT 2023
|
PRIMARY | Merck Index | ||
|
m5014
Created by
admin on Sat Dec 16 00:30:28 GMT 2023 , Edited by admin on Sat Dec 16 00:30:28 GMT 2023
|
PRIMARY | Merck Index | ||
|
ErythropoiesisStimulatingAgent
Created by
admin on Sat Dec 16 00:30:28 GMT 2023 , Edited by admin on Sat Dec 16 00:30:28 GMT 2023
|
PRIMARY | |||
|
11751549
Created by
admin on Sat Dec 16 00:30:28 GMT 2023 , Edited by admin on Sat Dec 16 00:30:28 GMT 2023
|
PRIMARY | |||
|
6384
Created by
admin on Sat Dec 16 00:30:28 GMT 2023 , Edited by admin on Sat Dec 16 00:30:28 GMT 2023
|
PRIMARY | |||
|
C477
Created by
admin on Sat Dec 16 00:30:28 GMT 2023 , Edited by admin on Sat Dec 16 00:30:28 GMT 2023
|
PRIMARY | |||
|
11096-26-7
Created by
admin on Sat Dec 16 00:30:28 GMT 2023 , Edited by admin on Sat Dec 16 00:30:28 GMT 2023
|
PRIMARY |
From | To |
---|---|
1_7 | 1_161 |
1_29 | 1_33 |
Glycosylation Type | MAMMALIAN |
Glycosylation Link Type | Site |
---|---|
N | 1_24 |
N | 1_38 |
N | 1_83 |
O | 1_126 |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SUB_CONCEPT->SUBSTANCE | |||
|
SUB_CONCEPT->SUBSTANCE | |||
|
BIOSIMILAR -> PARENT |
|
||
|
SUB_CONCEPT->SUBSTANCE | |||
|
SUB_CONCEPT->SUBSTANCE | |||
|
SUB_CONCEPT->SUBSTANCE | |||
|
SUB_CONCEPT->SUBSTANCE | |||
|
SUB_CONCEPT->SUBSTANCE | |||
|
ACTIVATOR OF EXPRESSION->TARGET |
|
||
|
SUB_CONCEPT->SUBSTANCE | |||
|
SUB_CONCEPT->SUBSTANCE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
MOL_WEIGHT:SDS-PAGE | CHEMICAL |
|
||||
Molecular Formula | CHEMICAL |
|